Showing results (251-260 of 265) with videos related to

Sort By:
Pageof 27
Oncogene|March 4, 2021
A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastomaBelamy B Cheung, Ane Kleynhans, Rituparna Mittra, et al.
International Journal of Cancer|November 8, 2022
Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastomaJanith A Seneviratne, Daniel R Carter, Rituparna Mittra, et al.
Nature Communications|July 7, 2021
Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemiaQuentin Van Thillo, Jolien De Bie, Janith A Seneviratne, et al.
Nature Communications|July 27, 2019
JMJD6 is a tumorigenic factor and therapeutic target in neuroblastomaMatthew Wong, Yuting Sun, Zhichao Xi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2015
Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted TreatmentIrina Lambertz, Candy Kumps, Shana Claeys, et al.
Communications Biology|October 14, 2024
Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesisBelamy B Cheung, Ritu Mittra, Jayne Murray, et al.
Cancer Research|September 11, 2019
Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding InterfaceJessica Koach, Jessica K Holien, Hassina Massudi, et al.
Nature Communications|November 7, 2019
The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35Pei Y Liu, Andrew E Tee, Giorgio Milazzo, et al.
Pageof 27